My Companies
Notification
Account
Log Out
Login
FDC International received UK MHRA marketing authorisation for Atropine 1.0% w/v Eye Drops, Solution. Context: extends the company’s ongoing international approval pipeline; no commercial launch or financial impact was disclosed.
FDC Approves Rs 120 Crore Buyback At Rs 500 Per Share
FDC Schedules October 27 Board Meeting To Consider Share Buyback Proposal
FDC Wins Eight-Month Stay In FSSAI Mislabeling Dispute